Clinical Trial

Vivacit-E Post-market Follow-up Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 1, 2025 (before its estimated March 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2017-07-19; most recent amendment 2024-12-30.
Trial Details
NCT Number NCT03226808
Lead Sponsor Zimmer Biomet
Conditions Osteoarthritis, Avascular Necrosis of Bone of Hip, Post-traumatic; Arthrosis, Congenital Hip Dysplasia
Enrollment 258 participants
Start Date 2013-10-01
Primary Completion 2026-03-02 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-01